Prolonged exposure to doxorubicin after radiotherapy in glioblastoma

Iacopo Sardi

doi:10.2217/fon.15.354

Prolonged exposure to doxorubicin after radiotherapy in glioblastoma

Future Oncol. 2016 Mar;12(5):581-3. doi: 10.2217/fon.15.354. Epub 2016 Jan 22.

Author

Iacopo Sardi¹

Affiliation

¹ Neuro-Oncology Unit, Department of Pediatric Oncology, Meyer Children's University Hospital, Florence, Italy.

PMID: 26794842
DOI: 10.2217/fon.15.354

No abstract available

Keywords: anthracyclines; blood–brain barrier; brain tumors; chemotherapy; doxorubicin; glioblastoma multiforme; high-grade glioma; radiotherapy; temozolomide; tumor stem cell.

Publication types

Editorial

MeSH terms

Anthracyclines / pharmacology
Anthracyclines / therapeutic use
Antibiotics, Antineoplastic / pharmacology
Antibiotics, Antineoplastic / therapeutic use*
Blood-Brain Barrier / drug effects
Blood-Brain Barrier / metabolism
Blood-Brain Barrier / radiation effects
Combined Modality Therapy
Doxorubicin / pharmacology
Doxorubicin / therapeutic use*
Glioblastoma / drug therapy*
Glioblastoma / mortality
Glioblastoma / radiotherapy
Humans
Permeability
Radiation
Radiotherapy / adverse effects
Time Factors

Substances

Anthracyclines
Antibiotics, Antineoplastic
Doxorubicin